Charm Therapeutics raised $50 million in a Series A funding round co-led by F-Prime Capital and OrbiMed.

AI (big data) Biotech Health services Software Services

Investments

05 June 2022

Charm Therapeutics (company)

AI (big data) Biotech Health services Software Services

Total investments received (USD): 130m

Round value (USD): 50m

Round investors: F-Prime Capital General Catalyst Khosla Ventures OrbiMed Advisors Braavos Capital Axial VC

Industry: AI (big data) Biotech Health services Software Services

AI (big data) Competitive Intelligence Energy Software Services

Investments 05 November 2022

Biotech Health services Pharma

Investments 19 September 2022

Biotech Health services Pharma

Investments 01 August 2022

Biotech Health services

Investments 02 July 2022

Biotech Health services

Investments 24 June 2022